AGG-523 is an aggrecanase specific inhibitor that has been shown to attenuate increases in synovial fluid ARG-aggrecan levels following surgically-induced joint instability in the rat MT model. Pharmacologic inhibition of aggrecanase activity in humans using AGG-523 may be an effective treatment for slowing cartilage degradation following joint injury.
Molecular Weight:
476.54
CAS Number:
[920289-29-8]
Formula:
C28H29FN2O4
Target:
Others|||Protease
T68344
* VAT and and shipping costs not included. Errors and price changes excepted
